ALINT.PA stock up 23.43% to €0.187 on EURONEXT 09 Feb 2026: volume surge may signal short-term reversal

ALINT.PA stock jumped 23.43% intraday to €0.187 on EURONEXT on 09 Feb 2026 after a surge in trading activity. The move pushed volume to 64,304 shares versus an average 12,299, a 5.23x increase that marks ALINT.PA stock among today’s high-volume movers. Traders are reacting to valuation signals and technical setups while fundamentals remain mixed, creating a short-term trading opportunity but heightened risk for longer-term investors.

ALINT.PA stock intraday snapshot

Price action: ALINT.PA stock traded between €0.145 and €0.187 today and closed at €0.187. Volume: today’s 64,304 shares are well above the 30-day average 12,299, marking strong intraday interest. Market context: The company is listed on EURONEXT in Europe and has a market cap of €971,199.00, with 6,606,796 shares outstanding.

ALINT.PA stock drivers and news

Catalyst: The intraday jump appears driven by short-covering and sector comparisons rather than fresh company releases. External health and competitor screens have shown renewed attention to the stock source. Data signals: Investing.com flagged Integragen’s financial health metrics, which can amplify moves in microcap biotech names source. Traders should link news flow to flow-through in share supply.

ALINT.PA stock fundamentals and valuation

Earnings and margins: IntegraGen SA reports EPS -€0.04 and PE -3.67, reflecting losses and small free cash flow. Revenue per share is €1.01 and book value per share is €0.05. Valuation: Price-to-sales is 0.15 and price-to-book is 2.87, implying the market prices a recovery slenderly above book. The balance sheet shows cash per share €0.26 and debt-to-equity 1.23.

ALINT.PA stock technicals and volume

Momentum: RSI sits at 43.73, below neutral, and ADX at 15.03 signals no strong trend. Price sits above the 50-day average €0.145 but below the 200-day average €0.278, a mixed technical picture. Volume profile: Today’s 64,304 vs avg 12,299 is a 5.23x jump. That spike typically precedes either a sustained breakout or a rapid reversion in microcap biotech names.

ALINT.PA stock grade and forecast

Meyka AI rates ALINT.PA with a score out of 100: 61.54 (Grade B) — HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a monthly price of €0.09, implying -51.87% versus the current €0.187. Forecasts are model-based projections and not guarantees. See our internal page for live updates: Meyka ALINT.PA.

ALINT.PA stock risks and outlook

Risks: Key risks include persistent operating losses, low liquidity, and debt-to-equity at 1.23. The company’s small market cap increases volatility and execution risk. Outlook: We set scenario targets. A conservative 12-month target is €0.25 (+33.69%) if revenue momentum returns. Bear case aligns with the model at €0.09 (-51.87%). Catalysts would be contract wins or clearer margin improvement.

Final Thoughts

ALINT.PA stock’s intraday surge to €0.187 on 09 Feb 2026 is firmly volume-driven and places the microcap biotech among today’s high-volume movers. Short-term traders may find momentum opportunities, while longer-term investors must weigh weak EPS (−€0.04), negative free cash flow, and thin liquidity. Meyka AI’s models give a cautious signal: Meyka AI’s forecast model projects €0.09 monthly, implying -51.87% downside versus today’s price. At the same time, an upside scenario to €0.25 or €0.30 is feasible if revenue or contract news arrives, implying +33.69% and +60.43% respectively. Our proprietary grade of 61.54 (B, HOLD) reflects mixed fundamentals and market context. For active traders, monitor volume, the 50-day €0.145 and 200-day €0.278 averages, and any company announcements. Forecasts are model-driven projections and not guarantees. Meyka AI provides this AI-powered market analysis to help investors parse fast moves and risk.

FAQs

What caused the ALINT.PA stock jump today?

The intraday jump to €0.187 was driven by a 5.23x volume spike and short-covering. No major company release was public, so sector screens and liquidity flows likely amplified the move.

What is Meyka AI’s view on ALINT.PA stock?

Meyka AI rates ALINT.PA 61.54 (B, HOLD). The model forecasts €0.09 monthly and flags mixed fundamentals, thin liquidity, and high volatility as key concerns.

What price targets should investors watch for ALINT.PA stock?

Watch a conservative upside target €0.25 (+33.69%) and a bear-case target €0.09 (−51.87%). Immediate technical levels are €0.145 (50-day) and €0.278 (200-day).

Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.